<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:srp="http://www.alacra.com/srp" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Isolagen, Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Isolagen, Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/Isolagen_Inc-2509593</link>
<lastBuildDate>Saturday, August 30, 2008 8:36:35 AM</lastBuildDate>
<alacra:xlsid>2509593</alacra:xlsid>
<alacra:company>Isolagen, Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-27415005</link><guid isPermaLink="false">newstex/PRN-0005-27415005</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> EXTON, Pa., Aug. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Isolagen(TM), Inc. (Amex: ILE) today announced that on August ##, #### it received notice from the American Stock Exchange (AMEX) advising the Company that its...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><pubDate>8/14/2008 8:24:28 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Isolagen, Inc. Receives American Stock Exchange Notice Accepting Its Previously Submitted Plan of Compliance and Canceling the Delisting Hearing</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-27415005</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">ISOLAGEN INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">ILE</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-27186352</link><guid isPermaLink="false">newstex/PRN-0005-27186352</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> EXTON, Pa., Aug. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Isolagen(TM), Inc. (Amex: ILE) announced today positive top-line efficacy and safety results from two pivotal, Phase III clinical studies (Studies IT-R-### and...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07005000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07013000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">01000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">01020000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13001000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13001002</newstex:cat><pubDate>8/5/2008 5:21:08 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-27186352</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">ISOLAGEN INC</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">DECLAN DALY</newstex:index_entry_person><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">NICHOLAS TETI</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">ILE</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-26699394</link><guid isPermaLink="false">newstex/PRN-0005-26699394</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> EXTON, Pa., Jul. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Isolagen(TM), Inc. (Amex: ILE) announced today that it has received a notice from the American Stock Exchange scheduling its oral hearing for Tuesday, August ##,...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><pubDate>7/16/2008 10:21:49 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Isolagen, Inc. Receives Notice of Hearing from American Stock Exchange</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-26699394</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">ISOLAGEN INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">ILE</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-25655770</link><guid isPermaLink="false">newstex/PRN-0005-25655770</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> EXTON, Pa., May ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Isolagen(TM), Inc. (Amex: ILE) today announced that on May ##, #### it received notice from the staff of the American Stock Exchange (AMEX) indicating that, in...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><pubDate>5/30/2008 6:15:24 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Isolagen, Inc. Reports Receipt of Initiation of Delisting Proceedings Notice from Amex</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-25655770</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">ISOLAGEN INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">ILE</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1816793</link><guid isPermaLink="false">ccbn/T1816793</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Okay. So, we're happy to have Isolagen here. Thanks for attending and with me I have Todd Greenspan, CFO, Declan Daly, CEO, and Nick Teti, Chairman. So, thanks for joining us, and I was just wondering if you could start with a ten-minute overview of your company for those who are not familiar? ...

</description><pubDate>5/2/2008 6:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">ISOLAGEN INC</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">ISOLAGEN INC at Morgan Stanley 2008 Global Healthcare Unplugged Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">ILE</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">3:40pm ET</ccbn:time><title>ISOLAGEN INC at Morgan Stanley 2008 Global Healthcare Unplugged Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1816793</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/bir/1359783</link><guid isPermaLink="false">bir/1359783</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>Isolagen Inc.</title><bir:company xmlns:bir="http://www.alacra.com/bir">Isolagen Inc.</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Manufacturing: Biotechnology company  focused on developing emergent, novel skin and tissue rejuvenation.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">2836</bir:sic><bir:naics xmlns:bir="http://www.alacra.com/bir">325414</bir:naics><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">A</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">B</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">ILE</bir:ticker><pubDate>3/29/2008 6:35:00 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">1359783</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/1484706635</link><guid isPermaLink="false">srp/1484706635</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><srp:company xmlns:srp="http://www.alacra.com/srp">1484706635</srp:company><title>Isolagen, Inc.</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">46488N103</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">ILE</srp:ticker><pubDate>10/6/2006 12:31:00 PM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">1484706635</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>